McCann FitzGerald advises Boston Scientific Corp. on Irish aspects of its acquisition of Cryterion Medical, Inc.

We advised Boston Scientific Corp. on the Irish aspects of its acquisition of Cryterion Medical, Inc. a private company developing a single-shot cryoablation platform for the treatment of atrial fibrillation, the most common form of heart arrhythmia. Cryterion Medical Ireland, Limited, a manufacturing subsidiary of Cryterion Medical, Inc., was included in the merger.